Bone marrow iron score as an indicator for secondary iron overload in acute myeloid leukemia patients.

Marlijn P A HoeksMarit van der PolRutger MiddelburgDorothea EversMarian van KraaijJaap Jan Zwaginga

Published in: European journal of haematology (2018)

In conclusion, the cumulative RBCT number is associated with BMIS. Due to the considerable variation in number of RBCT to reach a maximum BMIS, BMIS instead of only considering the cumulative RBCT number may be a valuable indicator of secondary iron overload in AML patients. BMIS could guide iron-lowering therapy and/or transfusion strategies in an early stage.

Keyphrases

end stage renal disease
early stage
bone marrow
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors
mesenchymal stem cells
cardiac surgery
radiation therapy
lymph node
allogeneic hematopoietic stem cell transplantation